Background: We performed this study to evaluate use of fresh and frozen sperm samples in non-obstructive azoospermia microdissection testicular sperm extraction (micro-TESE-ICSI) treatment. Methods: We performed a total of 82 consecutive in vitro fertilization (IVF) cycles at Fertijin IVF Center in Istanbul, Turkey from January 2010 to March 2012. In 43 participants we used fresh sperm and frozen sperm in the remaining 39 cases. We used fresh and frozen thawed micro surgical testicular sperm extraction (micro TESE) sperm for ICSI with metaphase II (MII) oocytes. Results: Frozen microTESE sperm was used in 39 cycles, while 43 ICSI cycles were performed using fresh microTESE. Neither the age of male partners (38.33±5.93 and 38.13±8.28) nor that of the female participants (33.16±6.38 and 33.33±6.97) showed significant difference between fresh versus the microTESE and frozen treatment groups, respectively. FSH concentrations were (14.66±13.93 mIU/ml) in fresh TESE group and (17.91±16.29 mIU/ml) in frozen group with no correlations or differences between the two groups. The average number of mature oocytes injected with sperm was 9.23±3.77, versus 9.26±5.26 in cycles using fresh and frozen microTESE sperm, respectively. Fertilization rate was not significantly different in the fresh microTESE (44.79%) than frozen TESE sperm group (46.76%). The average number of transferred embryos was 1.60±0.49 in fresh sperm group and 1.59±0.50 in frozen sperm group. All embryo transfers were performed on day 3. Conclusion: Cryopreservation of testicular sperm tissues is more suitable and of great benefite if carried out before ovulation induction and not after, especially in cases with non-obstructive azoospermia.
Introduction urgical techniques for testicular sperm retrieval, such as testicular sperm extraction (TESE) and microsurgical testicular sperm extraction (mTESE), are prerequisites for treating infertile men (1) . Azoospermia due to spermatogenic failure may be classified as primary or secondary. Primary disorders may be of genetic origin, such as microdeletions in Y-chromosome, or of congenital origin as in cryptorchidism (2) . Secondary causes may be due to chemo-or radiotherapy or endocrine dysfunctions (3) . Testicular histology generally demonstrates maturation arrest or complete absence of germ cells (4) . Male factor infertility represents almost one-third of infertility cases, out of which azoospermia may comprise up to 10% (5) . Azoospermia can be either obstructive azoo-spermia (OA) or non-obstructive azoospermia (NOA). In OA, there is a blockage in the transfer pathway of sperm. In all OA and most of NOA cases, sperm can be retrieved from the testis via microTESE (6, 7) . In severe cases, there may be only scattered foci of sperm production and more extensive biopsy may be needed to recover tubules with mature sperm.
Different studies have shown that the combination of human testicular sperm biopsy and intracytoplasmic sperm injection (ICSI) are efficient methods in the treatment of male infertility with azoospermia (8, 9) . The successful use of TESE procedures with ICSI led to the use of cryopreserved-thawed spermatozoa. The addition of sperm cryopreservation is valuable as it may reduce the number of procedures required for pregnancy success, and repeated testicular biopsies can then be avoided (10) . It seems that comparable success could be achieved with frozen-thawed and testis spermatozoa (11, 12) . However, limited pieces of data exist about different factors connected with the efficacy of ICSI using frozen nonmotile testicular spermatozoa. Dafopoulos et al. reported in their study that they used motile spermatozoa for ICSI in 159 cycles while they used immotile spermatozoa in 138 other cycles (13) .
The aim of this study was to compare use of fresh and frozen sperm samples in non-obstructive azoospermia through microdissection testicular sperm extraction (microTESE) treatment.
Methods

Patients:
A total of 82 consecutive IVF cycles were performed at the Fertijin IVF Center in Istanbul, Turkey from January 2010 to March 2012. This center has been approved by the Ministry of Health of Turkey and; therefore, under its ethical rules. In the study, we used fresh sperm in 43 and frozen sperm in 39 participants with non-obstructive azoospermia. Fresh and frozen thawed m-TESE sperm were used for ICSI with metaphase II (MII) oocytes.
Surgical procedures: Micro-TESE was performed under general anesthesia by removing off testicular tissue through a transversal incision of the albuginea, either equatorially or in the cranial part of the testis. In microTESE, an incision was made on the testes, covering three-quarters of its circumference and oriented to preserve the predominantly transversal subalbugineal vessels. The testicular pulp, was searched under the operative microscope (×12 to 24 magnification) for areas with dilated tubules, and several tiny fragments (approx. 2×2×2 mm 3 ) of the testicular tissue were sampled from the two separate surfaces, at different levels of depth from the albuginea to the hilum. The volume of testicular tissue collected by microTESE for sperm search was roughly the same. At the time of surgery, a testicular biopsy from the subalbugineal pulp was also made. Some of the patients had pathology reports from previous biopsies but it was the first time for most of them. We cryopreserved the rest of fresh m-TESE sperm after ICSI.
Biological search for spermatozoa and freezing:
Testicular fragments were washed in Earl's Balanced Salt Solution (EBSS Sigma, USA) medium to remove blood, then they were placed in sterile glass petri dishes with 0.5 ml of Sperm Washing Medium™ (from Vitrolife, Sweden), and finely minced using insulin enjection needls and while being stirred to a homogeneous suspension, they were directly examined under an inverted microscope at ×200 and ×400 magnifications (Diaphot, Nikon, Japan) for the presence of spermatozoa, the search lasting up to 1 hr. Sperm search was performed in all cases by the same operator, and the results were expressed as positive when at least one recoverable sperm was observed (7) . The sperm were frozen on the same day with Vitrolife sperm freezing medium (Vitrolife Sweden). Testicular tissues were mixed 1:1 with sperm freezing medium in sperm cryo vial after labeling stayed 20 min at −20°C in deep freeze and then put on liquid nitrogen vapour freezing technique as mentioned by Dafopoulos (14) . If we collected oocytes on the same day, we used fresh testicular sperm samples after centrifuging it for 15 min at 2000 rpm (Heraeuse Labofuge 400, Germany) (15) . Thawing was performed at room temperature for 15 min. The preparation was then separated from the cryoprotectant by washing in culture medium and centrifugation at 2000 rpm for 15 min. The resulting pellet was resuspended in 500 μl of culture medium (Vitrolife, Sweden).
Ovarian Stimulation: All female partners were stimulated using gonadotropin releasing hormone agonist or antagonist, in combination with human menopausal gonadotropin, and/ or recombinant human FSH. Human chorionic gonadotropin was administered when optimal follicle development was achieved, as evaluated by serial transvaginal ultrasound (GE Logiq P5, USA). Oocyte retrieval was perform sonographic after huma (16 All embryo transfers were performed on day 3. Embryo quality was evaluated as good or poor depending on the fragmentation percentage, blastomere count and multinucleation absence prior to transfer. In groups using fresh mTESE sperm, 58.1% were of good and 41.9% of poor embryo qualities, and nearly similar results were produced in the frozen sperm group, 51.3% were of good and 48.7% were of poor quality.
Clinical pregnancy was achieved in 19 couples (44.2%) and 17 couples (43.6%), respectively, in groups using fresh and frozen TESE sperm. Delivery rate was similar between groups. Nineteen pregnancies were established using fresh TESE and resulted in the delivery of 12 healthy neonates. In the frozen TESE group, 17 clinical pregnancies were delivered, resulting in the birth of 10 healthy neonates. Two pregnancies resulted in spontaneous abortion in the fresh sperm group and four abortions occurred in the frozen one. No congenital anomalies or major malformations were noted in both groups (Table 2) .
Discussion
Several authors have demonstrated that performing ICSI with fresh or frozen spermatozoa will produce similar results (12, 16, 19, 20) and that freezing does not affect spermatozoa (21) . Sperm recovery rate for ICSI treatment was between 60% to 70% in patients with non-obstructive azoospermia (22) but in our study it was between 30% to 40%. In some cases there were no clear relationship evidence parameters and results, for example between serum FSH concentrations and testicular volume measurements to predict success rate especially in patients with sertoli cell only syndrome or maturation arrest (23) . Although, FSH concentration showed no significant difference between the two groups, its concentration correlated with sperm count. However, when sperm collection was not possible on the day of oocyte retrieval for ICSI in some cases, we offered the couples to throw or cryopreserve their oocytes. In these cases, cryopreservtion of testicular spermatozoa with diagnostic biopsy or TESE attempt for future ICSI cycles, would avoid both unnecessary female stimulation and the need for repetative biopsies for sucessive ICSI cycles (24) . This approach has been shown to be feasible (19) . Testicular sperm could be frozen within testicular tissue with minimal processing of testicular tissue or after being extracted and purified from the tissue. The prefered method may be to freeze the tissue intact as this allows better post-thaw survival and motility rate (25) . Our method was very simple, with fast and good result as compared to other studies. The results showed that the combination of human testicular sperm biopsy and intracytoplasmatic sperm injection (ICSI) was an efficient method for the treatment of male infertility with azoospermia. Some authors have reported fertilization rates between 44% to 63% (19), em- (30) which involved comparison of fertilization rates with ICSI for fresh and frozen testicular sperm, frozen testicular sperm had possibly lower fertilization rates than the ejaculated or fresh epididymal sperm (53.4% vs. 64.8%, and 58.5% respectively). However, when we compared fresh and frozen testicular tissues, we achieved similar fertilization rates for fresh and frozen sperm (44.7% and 46.7%, respectively). Moreover, in one study on comparing the pregnancy rate (30), the rates were 33.6% and 44.3% for fresh and the frozen groups, respectively, but our findings showed 44.2% for fresh and 43.6% for frozen sperm. We achieved 19 pregnancies in fresh mTESE sperm group, although 2 of them were later aborted. Birth rate was %37.2 in this group and 17 pregnancies were achieved in frozen mTESE group, although 4 of which were later aborted. Birth rate was 30.8%. However, our results demonstrated that fresh and frozen-thawed testicular spermatozoa used in ICSI procedure which involved culture and transfer of embryos on day 3 yielded similar results in the two groups. Moreover, there were no significant differences in embryo cleavage rates, quality of embryos, fertilization rate or clinical pregnancy outcomes between the two groups.
Conclusion
Based on our findings, use of frozen TESE seems to be the best way to avoid unnecessary ovulation induction. Regarding the findings of this study, cryopreservation of testicular sperm tissues seems to be more suitable and of great benefit in these cases and good results are expected when ICSI is carried out before and not after ovulation induction, especially in cases with nonobstructive azoospermia. More evidence is needed through studies with larger sample sizes and different communities to draw a conclusion about the subject in this region using.
